J2354 Octreotide injection, non-depot
Also known as: octreotide, Sandostatin
Injection of octreotide, non-depot formulation. A short-acting somatostatin analog for acute suppression.
In Plain Language
hormone control injection; acromegaly and carcinoid treatment
Clinical Context
Used for acute symptom suppression in acromegaly, carcinoid crisis, and neuroendocrine emergencies. Short duration requires multiple daily injections.
RVU Information
CPT J2354 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2354?
CPT J2354 (Octreotide injection, non-depot) is a J Codes (Drugs) code. Injection of octreotide, non-depot formulation. A short-acting somatostatin analog for acute suppression.
How is J2354 administered?
CPT J2354 is administered by a healthcare provider, typically via injection or infusion. Used for acute symptom suppression in acromegaly, carcinoid crisis, and neuroendocrine emergencies. Short duration requires multiple daily injections. It is used by Endocrinology, Oncology.
When is CPT J2354 used?
Used for acute symptom suppression in acromegaly, carcinoid crisis, and neuroendocrine emergencies. Short duration requires multiple daily injections.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.